Her2-positive breast cancer - Globe Thesis

Keyword [Her2-positive breast cancer] Result: 1 - 20 \| Page: 1 of 3
1.	The Mechanism Of Apoptosis Induced By Lapatinib In Her2 Positive Breast Cancer Cells And Synergistic Effective Between ABT-737 And Lapatinib
2.	Contrastive Analysis Of Clinicopathologic Features And Prognosis Between Triple Negative Breast Cancer And HR Negative/HER2 Positive Breast Cancer
3.	Novel Role Of MiR-375in Trastuzumab-resistance And Metastasis Of HER2-positive Breast Cancer
4.	Study On AG490-enhanced Trastuzumab Sensitivity In HER2-positive Breast Cancer Cells
5.	Study On The Role Of PRAS40 Phosphorylation At Thr246 In The Development Of Trastuzumab Resistance In HER2-positive Breast Cancer
6.	A Research On Drug-resistant Mutations In HER2-positive Breast Cancer Based On Circulating Tumor DNA And CRISPR/cas9 Technique
7.	Studies On Prognostic Prediction In HER2 Positive Breast Cancer And Treatment In Triple Negative Breast Cancer
8.	MicroRNA-608Impacts Susceptibility And Progress Of HER2-positive Breast Cancer
9.	Mechanism And Functional Research Of Autophagy Promoting Lapatinib Resistance Of HER2-Positive Breast Cancer Cells
10.	Experimental Animal Study Of DCIK-Her2 Cell Anti-tumor Effect In Her2 Positive Breast Cancer
11.	Ⅰ-Ⅱ Phase HER2 Positive Breast Cancer Neoadjuvant Therapy Efficacy And The Related Clinical Pathologic Factors Of Prospective Studies
12.	Endocytic Mechanisms Of The Antibody-Drug Conjugates Targeting HER2-Positive Breast Cancer Cell
13.	Study On Prognostic Indicators Of Breast Cancer
14.	Down-Regulation Of Filamin A Expression Impacts Biological Behaviour Of HER2 Positive Breast Cancer Cells
15.	PPT Induces HER2-Positive Breast Cancer Cells Apoptosis And Related Mechanism Research
16.	High Plasma Fibrinogen Is Correlated With Poor Response To Trastuzumab Treatment In HER2 Positive Breast Cancer
17.	The Synergetic Efficacy And Mechanism Of NVP-BEZ235 And STA-9090 Against HER2-positive Breast Cancer Cell Lines
18.	The Mechanism Study Of The NRG1/HER3 Activation In The Primary Resistance Of HER2-positive Breast Cancer To Trastuzumab
19.	The Exploration Of Prognostic Factors And Predictive Factors For Response To Neoadjuvant Therapy In Early-stage Breast Cancer
20.	The Role And Mechanism Of EPHA5 In The Trastuzumab Resistance Of HER2-positive Breast Cancer
<<First <Prev Next> Last>> Jump to